Cyclic AMP potentiates down regulation of epidermal growth factor receptors by platelet-derived growth factor.
D015056:1-Methyl-3-isobutylxanthine / Q000494:pharmacology; D015124:8-Bromo Cyclic Adenosine Monophosphate; D000818:Animals; D002460:Cell Line; D002478:Cells, Cultured; D002772:Cholera Toxin / Q000494:pharmacology; D000242:Cyclic AMP / Q000031:analogs & derivatives / Q000378:metabolism* / Q000494:pharmacology; D004261:DNA Replication / Q000187:drug effects; D015237:Dinoprost; D004357:Drug Synergism; D004815:Epidermal Growth Factor / Q000378:metabolism*; D066246:ErbB Receptors; D006133:Growth Substances / Q000494:pharmacology; D007700:Kinetics; D051379:Mice; D008807:Mice, Inbred BALB C; D008934:Mitogens / Q000494:pharmacology*; D010455:Peptides / Q000494:pharmacology; D010982:Platelet-Derived Growth Factor; D011460:Prostaglandins F / Q000494:pharmacology; D011956:Receptors, Cell Surface / Q000187:drug effects / Q000378:metabolism*
D006133:Growth Substances; D008934:Mitogens; D010455:Peptides; D010982:Platelet-Derived Growth Factor; D011460:Prostaglandins F; D011956:Receptors, Cell Surface; D015124:8-Bromo Cyclic Adenosine Monophosphate; D004815:Epidermal Growth Factor; D002772:Cholera Toxin; D015237:Dinoprost; D000242:Cyclic AMP; D066246:ErbB Receptors; D015056:1-Methyl-3-isobutylxanthine